Cardiovascular & Soft Tissue Repair Patch Market

Cardiovascular & Soft Tissue Repair Patch Market (Product: Synthetic Patch and Biologic Patch [Xenogeneic Patch and Allogeneic Patch]; Application: Cardiovascular Repair [Cardiac Reconstruction and Vascular Reconstruction] and Soft Tissue Repair [Abdominal Wall Reconstruction, Thoracic Wall Reconstruction, Dural Reconstruction, Hernia Repair, and Others]; and End User: Hospitals, Ambulatory Surgical Centers, and Specialty Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Progress in Tissue Engineering to Drive Global Market

The past couple of decades have witnessed significant progress in technology that has played a key role in improving the different cardiac treatments and patient outcomes. Advancements in biomedicine have led to an increase in the deployment of natural bio polyesters such as polyhydroxyalkanoates (PHA) for an array of applications. As PHAs are biodegradable, biocompatible, and non-toxic, they are used in multiple applications as biomaterials. PHAs are also used in the implantology space as valves and sutures in the tissue engineering field as substitutes for a bone graft and cardiovascular patches. The significant rise in the number of congenital & acquired cardiovascular and soft tissue anomalies, rising demand for biologics for hernia and other soft tissue repair, and rapid progress in biomaterial and tissue engineering are some of the major factors that are expected to drive the cardiovascular & soft tissue repair patch market during the forecast period (2019-2027).

Research and development activities in the cardiovascular & soft tissue repair patch market are on the rise as healthcare providers continue to find new materials that will improve the effectiveness of these patches. Growing adoption of cardiovascular & soft tissue repair patches particularly for cardiac tissue engineering is expected to be a major driver that is projected to steer the global cardiovascular & soft tissue repair patch market past the ~US$ 4.4 Bn mark by the end of 2027.

cardiovascular soft tissue repair patch market infographic

To know the scope of our report Get a Sample on Cardiovascular & Soft Tissue Repair Patch Market

Improvements in Bio-based Techniques to Treat Cardiac Regeneration Likely to Fuel Demand

Cardiovascular diseases are the leading causes of death worldwide and the numbers surge each year. Of all major cardiovascular diseases, the prevalence of myocardial infarction (MI) is the highest. Another major cardiovascular condition that is likely to be a burden on the global healthcare systems is heart failure wherein the heart loses its functional capabilities. While there is no concrete treatment for heart failure, research and development activities continue to open up new opportunities in this field.

Get a glimpse of the in-depth analysis through our Report Brochure

In the past couple of decades, tissue regeneration to enhance cardiac degeneration and mitigate heart failure has emerged as an ideal solution wherein cardiovascular & soft tissue repair patches made of biomaterials are used. Apart from tissue engineering, noteworthy advancements in regenerative medicine have also opened up new opportunities for stakeholders in the cardiovascular & soft tissue repair patch market. Over the past few years, participants of the cardiovascular & soft tissue repair patch market are focusing on the development of biomaterial-based strategies to overcome cardiac regeneration post-myocardial infarction. In the current scenario, the two major techniques deployed for tissue engineering include cardiac patches and in situ gelling systems. Cardiovascular & soft tissue repair patches consist of cells and bioactive molecules that aid in the therapeutic healing and repair of soft tissues. Despite emerging as one of the most reliable and effective tissue engineering techniques, cardiovascular & soft tissue repair patches have received flak, as they require invasive surgeries for implantation. In the past few years, in situ gel systems gaining popularity. However, it could dent the prospects of cardiovascular & soft tissue repair patches in the near future.

R&D Paves Way for New Cardiovascular & Soft Tissue Repair Patches

Research and development activities have been critical in the field of biomedicine and biomedical engineering. Witnessing the growing demand for efficient solutions to repair or heal the structural changes of the heart post-myocardial infarction treatment has encouraged research and development in the current cardiovascular & soft tissue repair patch market. While stem cell therapies have offered significant promise in providing assistance for cardiac repair, the low retention capacity of the transplanted stem cells poses a major hurdle. Various drawbacks of alternative techniques to aid cardiac repair have encouraged researchers to focus on the discovery of new solutions.

For instance, a group of researchers from the U.S. and South Korea designed a new stretchable cardiovascular & soft tissue repair patch made using a cell-derived extracellular matrix (ECM). According to the researchers, ECM can play an important role in enhancing the adhesion of stem cells and accelerate the recovery process. Investments in research and development activities are expected to grow at a steady pace in the coming years due to which, new therapeutic cardiovascular & soft tissue repair patches are being developed using new biomaterials.

cardiovascular soft tissue repair patch market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

The global cardiovascular & soft tissue repair patch market is expected to grow at an impressive CAGR of ~10% during the forecast period. The market growth can be attributed to a range of factors, including rise in the prevalence of congenital & acquired cardiovascular and soft tissue anomalies and ascending demand for biologics for hernia and a range of other soft tissue repair applications. Stakeholders in the current cardiovascular & soft tissue repair patch market should focus on research and development activities to develop new and effective therapeutic cardiac patches. In addition, developments in the biomaterial and tissue engineering space are further expected to boost the prospects of the market for cardiovascular & soft tissue repair patches.

Cardiovascular & Soft Tissue Repair Patch Market: Overview

  • According to Transparency Market Research’s latest market report on the global cardiovascular & soft tissue repair patch market for the historical period (2017–2018) and forecast period (2019–2027), increase in geriatric population and rise in prevalence of congenital & acquired cardiovascular and soft tissue anomalies are projected to boost the growth of the global cardiovascular & soft tissue repair patch market during the forecast period. Moreover, inclination toward minimally invasive procedures is anticipated to fuel the growth of the global cardiovascular & soft tissue repair patch market.
  • According to the report, the global cardiovascular & soft tissue repair patch market was valued at US$ 1.9 Bn in 2018 and is expected to expand at a CAGR of ~10% from 2019 to 2027

Rise in Prevalence of Congenital & Acquired Cardiovascular and Soft Tissue Anomalies: Key Drivers

  • The number of people with congenital heart defects is increasing across the globe due to changes in lifestyle, dietary habits, and physical inactivity. Rise in prevalence of congenital heart defects such as atrial septal defects and ventricular septal defects is likely to fuel the growth of the global cardiovascular & soft tissue repair patch market.
  • According to the Centers for Disease Control and Prevention, an estimated 1% (40,000) babies are born with congenital heart defect in the U.S. every year, and ventricular septal defect (VSD) is the most common heart defect
  • Rise in demand for biologics, owing to increase in soft tissue repair procedures is likely to propel the cardiovascular & soft tissue repair patch market. According to the U.S. Food and Drug Administration, over 1 million hernia repairs are performed in the U.S. each year.
  • Increase in incidence of abdominal and other types of hernia, surge in usage of biologic patches i.e., xenogeneic patch & allogeneic patch, and inclination toward minimally invasive procedures leading to rise in demand for biologic cardiovascular & soft tissue repair patch products

Increase in Geriatric Population

  • The geriatric population is at high risk of developing heart-related problems. Aging leads to accentuated adverse remodeling and increased dysfunction of cardiac mechanism. As the population continues to age, older patients are being referred for repair of acquired VSD. Hence, increase in the geriatric population is projected to accelerate the growth of the cardiovascular & soft tissue repair patch market during the forecast period.
  • According to the U.S. Department of Health & Human Product estimates, the U.S. will have about 72.1 million elderly people by 2030, which is more than twice the number in 2000
  • According to World Population Prospects: the 2019 Revision, the population aged 65 and above is increasing faster than all other age groups across the globe

Availability of Alternate Treatments and Complications Associated with Patches Restrain Global Market

  • Cardiovascular & soft tissue repair are common procedures performed across the world. Herniorrhaphy and hernioplasty are the alternative treatments for hernia repair.
  • Mesh for hernia repair and valve for cardiovascular repair are used significantly across the globe. Hence, alternative treatments are likely to hamper the growth of the cardiovascular & soft tissue repair market.
  • Adhesion, seroma, recurrence of soft tissue defects or hernia, allergic reactions, and hematomas are the complications associated with patches which restrict their usage. This factor hampers the growth of the global cardiovascular & soft tissue repair patch market.

Cardiovascular & Soft Tissue Repair Patch Market: Competition Landscape

  • This report profiles major players in the global cardiovascular & soft tissue repair patch market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global cardiovascular & soft tissue repair patch market is moderately fragmented, with presence of a small number of large players in international markets and large number of small players in regional markets. Top 4 to 5 players hold majority share of the global cardiovascular & soft tissue repair patch market. Prominent players operating in the global cardiovascular & soft tissue repair patch market include
    • W. L. Gore & Associates, Inc.
    • BD, Edwards Lifesciences Corporation
    • CryoLife, Inc.
    • Baxter
    • Johnson & Johnson (Medical Devices Business Services, Inc.)
    • Aesculap, Inc. (B. Braun company)
    • Nurami Medical Nanofiber Technology
    • Medtronic
    • FOC Medical S.A.
    • Medprin Regenerative Medical Technologies Co., Ltd.
    • CorMatrix, Inc.
    • Terumo Corporation
    • Lamed GmbH
    •  South America Implants S.A.

Cardiovascular & Soft Tissue Repair Patch Market: Key Developments

  • Leading players in the global cardiovascular & soft tissue repair patch market are engaged in the development and approval of new products, merger & acquisitions, and collaborations. Strategies adopted by key players are likely to boost the growth of the global cardiovascular & soft tissue repair patch market. Strategies adopted by the players in the global cardiovascular & soft tissue repair patch market are:
    • In December 2019, Baxter acquired Seprafilm to expand its advanced surgery portfolio
    • In June 2019, CorMatrix, Inc. announced the U.S. Food and Drug Administration approval for the Cor PATCH for pericardial tissue repair and support in adult patients
    • In September 2018, South America Implants S.A. entered into a distribution agreement with Minimal Medics Co. to expand internationally
    • In November 2016, W. L. Gore & Associates, Inc. joined with leaders across the vascular and endovascular community in honoring five North American physicians
  • The report on the global cardiovascular & soft tissue repair patch market discusses individual strategies, followed by company profiles of manufacturers of cardiovascular & soft tissue repair patches. The competitive landscape section is included in the cardiovascular & soft tissue repair patch market report to provide readers with a dashboard view and a company market share analysis of key players operating in the global cardiovascular & soft tissue repair patch market.

Cardiovascular & Soft Tissue Repair Patch Market - Segmentation

Product

Synthetic Patch

Biologic Patch

  • Xenogeneic Patch
  • Allogeneic Patch

Application

Cardiovascular Repair

  • Cardiac Reconstruction
  • Vascular Reconstruction

Soft Tissue Repair

  • Abdominal Wall Reconstruction
  • Thoracic Wall Reconstruction
  • Dural Reconstruction
  • Hernia Repair
  • Others

End User

Hospitals

Ambulatory Surgical Centers

Specialty Clinics

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Frequently Asked Questions

What is the total market worth of cardiovascular & soft tissue repair patch market?

Cardiovascular & soft tissue repair patch market is expected to expand at a CAGR of ~10% from 2019 to 2027

What is the anticipated CAGR of the cardiovascular & soft tissue repair patch market in the forecast period?

Cardiovascular & soft tissue repair patch market to reach valuation of ~US$ 4.4 Bn by 2027

What are the key driving factors for the growth of the cardiovascular & soft tissue repair patch market?

Cardiovascular & soft tissue repair patch market is driven by rise in prevalence of congenital & acquired cardiovascular and soft tissue anomalies

Which is the rising prominent segment in the cardiovascular & soft tissue repair patch market?

The biologic patch segment accounted for major share of the global cardiovascular & soft tissue repair patch market

Who are the key players in the cardiovascular & soft tissue repair patch market?

Key players in the global cardiovascular & soft tissue repair patch market include W. L. Gore & Associates, Inc., BD, Edwards Lifesciences Corporation, CryoLife, Inc., Baxter Johnson & Johnson (Medical Devices Business Services, Inc.)

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Cardiovascular & Soft Tissue Repair Patch Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution/Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast, 2017–2027

    5. Market Outlook

        5.1. Key Industry Events (product launch and approval, key merger & acquisition, etc.)

        5.2. Overview of Cardiovascular and Soft Tissue Repair Patch 

        5.3. Epidemiology of Cardiovascular Diseases, Soft Tissue Injury, Dural Injuries, Peripheral Injuries, by Region/Country 

    6. Global Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast, by Product

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Product, 2017–2027

            6.3.1. Synthetic Patch

            6.3.2. Biologic Patch 

                6.3.2.1. Xenogeneic Patch 

                6.3.2.2. Allogeneic Patch

        6.4. Global Cardiovascular & Soft Tissue Repair Patch Market Attractiveness, by Product 

    7. Global Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast, by Application

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Global Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Application, 2017–2027

            7.3.1. Cardiovascular Repair 

                7.3.1.1. Cardiac Reconstruction

                7.3.1.2. Vascular Reconstruction

            7.3.2. Soft Tissue Repair 

                7.3.2.1. Abdominal Wall Reconstruction

                7.3.2.2. Thoracic Wall Reconstruction

                7.3.2.3. Dural Reconstruction

                7.3.2.4. Hernia Repair 

                7.3.2.5. Others

        7.4. Global Cardiovascular & Soft Tissue Repair Patch Market Attractiveness, by Application

    8. Global Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast, by End-user 

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Global Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by End-user, 2017–2027

            8.3.1. Hospitals

            8.3.2. Ambulatory Surgical Centers

            8.3.3. Specialty Clinics

        8.4. Global Cardiovascular & Soft Tissue Repair Patch Market Attractiveness, by End-user 

    9. Global Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region

            9.2.1. North America 

            9.2.2. Europe 

            9.2.3. Asia Pacific 

            9.2.4. Latin America 

            9.2.5. Middle East & Africa 

        9.3. Global Cardiovascular & Soft Tissue Repair Patch Market Attractiveness, by Country/Region

    10. North America Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. North America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Product, 2017–2027

            10.2.1. Synthetic Patch

            10.2.2. Biologic Patch 

                10.2.2.1. Xenogeneic Patch 

                10.2.2.2. Allogeneic Patch

        10.3. North America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Application, 2017–2027

            10.3.1. Cardiovascular Repair 

                10.3.1.1. Cardiac Reconstruction

                10.3.1.2. Vascular Reconstruction

            10.3.2. Soft Tissue Repair 

                10.3.2.1. Abdominal Wall Reconstruction

                10.3.2.2. Thoracic Wall Reconstruction

                10.3.2.3. Dural Reconstruction

                10.3.2.4. Hernia Repair 

                10.3.2.5. Others

        10.4. North America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by End-user, 2017–2027

            10.4.1. Hospitals

            10.4.2. Ambulatory Surgical Centers

            10.4.3. Specialty Clinics

        10.5. North America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Country, 2017–2027

            10.5.1. U.S.

            10.5.2. Canada

        10.6. North America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis 

            10.6.1. By Product 

            10.6.2. By Application

            10.6.3. By End-user 

            10.6.4. By Country

    11. Europe Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Europe Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Product, 2017–2027

            11.2.1. Synthetic Patch

            11.2.2. Biologic Patch 

                11.2.2.1. Xenogeneic Patch 

                11.2.2.2. Allogeneic Patch

        11.3. Europe Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Application, 2017–2027

            11.3.1. Cardiovascular Repair 

                11.3.1.1. Cardiac Reconstruction

                11.3.1.2. Vascular Reconstruction

            11.3.2. Soft Tissue Repair 

                11.3.2.1. Abdominal Wall Reconstruction

                11.3.2.2. Thoracic Wall Reconstruction

                11.3.2.3. Dural Reconstruction

                11.3.2.4. Hernia Repair 

                11.3.2.5. Others

        11.4. Europe Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by End-user, 2017–2027

            11.4.1. Hospitals

            11.4.2. Ambulatory Surgical Centers

            11.4.3. Specialty Clinics

        11.5. Europe Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Country/Sub-region, 2017–2027

            11.5.1. Germany

            11.5.2. U.K.

            11.5.3. France

            11.5.4. Spain

            11.5.5. Italy

            11.5.6. Rest of Europe

        11.6. Europe Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis 

            11.6.1. By Product 

            11.6.2. By Application

            11.6.3. By End-user 

            11.6.4. By Country/Sub-region

    12. Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Product, 2017–2027

            12.2.1. Synthetic Patch

            12.2.2. Biologic Patch 

                12.2.2.1. Xenogeneic Patch 

                12.2.2.2. Allogeneic Patch

        12.3. Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Application, 2017–2027

            12.3.1. Cardiovascular Repair 

                12.3.1.1. Cardiac Reconstruction

                12.3.1.2. Vascular Reconstruction

            12.3.2. Soft Tissue Repair 

                12.3.2.1. Abdominal Wall Reconstruction

                12.3.2.2. Thoracic Wall Reconstruction

                12.3.2.3. Dural Reconstruction

                12.3.2.4. Hernia Repair 

                12.3.2.5. Others

        12.4. Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by End-user, 2017–2027

            12.4.1. Hospitals

            12.4.2. Ambulatory Surgical Centers

            12.4.3. Specialty Clinics

        12.5. Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Country/Sub-region, 2017–2027

            12.5.1. China

            12.5.2. Japan

            12.5.3. India

            12.5.4. Australia & New Zealand

            12.5.5. Rest of Asia Pacific

        12.6. Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis 

            12.6.1. By Product 

            12.6.2. By Application

            12.6.3. By End-user 

            12.6.4. By Country/Sub-region

    13. Latin America Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Latin America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Product, 2017–2027

            13.2.1. Synthetic Patch

            13.2.2. Biologic Patch 

                13.2.2.1. Xenogeneic Patch 

                13.2.2.2. Allogeneic Patch

        13.3. Latin America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Application, 2017–2027

            13.3.1. Cardiovascular Repair 

                13.3.1.1. Cardiac Reconstruction

                13.3.1.2. Vascular Reconstruction

            13.3.2. Soft Tissue Repair 

                13.3.2.1. Abdominal Wall Reconstruction

                13.3.2.2. Thoracic Wall Reconstruction

                13.3.2.3. Dural Reconstruction

                13.3.2.4. Hernia Repair 

                13.3.2.5. Others

        13.4. Latin America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by End-user, 2017–2027

            13.4.1. Hospitals

            13.4.2. Ambulatory Surgical Centers

            13.4.3. Specialty Clinics

        13.5. Latin America Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Country/Sub-region, 2017–2027

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America

        13.6. Latin America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis 

            13.6.1. By Product 

            13.6.2. By Application

            13.6.3. By End-user 

            13.6.4. By Country/Sub-region

    14. Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Product, 2017–2027

            14.2.1. Synthetic Patch

            14.2.2. Biologic Patch 

                14.2.2.1. Xenogeneic Patch 

                14.2.2.2. Allogeneic Patch

        14.3. Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Application, 2017–2027

            14.3.1. Cardiovascular Repair 

                14.3.1.1. Cardiac Reconstruction

                14.3.1.2. Vascular Reconstruction

            14.3.2. Soft Tissue Repair 

                14.3.2.1. Abdominal Wall Reconstruction

                14.3.2.2. Thoracic Wall Reconstruction

                14.3.2.3. Dural Reconstruction

                14.3.2.4. Hernia Repair 

                14.3.2.5. Others

        14.4. Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by End-user, 2017–2027

            14.4.1. Hospitals

            14.4.2. Ambulatory Surgical Centers

            14.4.3. Specialty Clinics

        14.5. Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value Forecast, by Country/Sub-region, 2017–2027

            14.5.1. GCC Countries

            14.5.2. South Africa

            14.5.3. Rest of Middle East & Africa

        14.6. Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis 

            14.6.1. By Product 

            14.6.2. By Application

            14.6.3. By End-user 

            14.6.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competition Matrix (By Tier and Size of companies)

        15.2. Market Share Analysis/Ranking, by Company, 2018

        15.3. Company Profiles

            15.3.1. W. L. Gore & Associates, Inc. 

                15.3.1.1. Company Overview

                15.3.1.2. Growth Strategies

                15.3.1.3. SWOT Analysis

            15.3.2. BD

                15.3.2.1. Company Overview

                15.3.2.2. Company Financials

                15.3.2.3. Growth Strategies

                15.3.2.4. SWOT Analysis

            15.3.3. Edwards Lifesciences Corporation 

                15.3.3.1. Company Overview

                15.3.3.2. Company Financials

                15.3.3.3. Growth Strategies

                15.3.3.4. SWOT Analysis

            15.3.4. CryoLife, Inc.

                15.3.4.1. Company Overview

                15.3.4.2. Company Financials

                15.3.4.3. Growth Strategies

                15.3.4.4. SWOT Analysis

            15.3.5. Baxter International, Inc.

                15.3.5.1. Company Overview

                15.3.5.2. Company Financials

                15.3.5.3. Growth Strategies

                15.3.5.4. SWOT Analysis

            15.3.6. Johnson & Johnson (Medical Devices Business Services, Inc.) 

                15.3.6.1. Company Overview

                15.3.6.2. Company Financials

                15.3.6.3. Growth Strategies

                15.3.6.4. SWOT Analysis

            15.3.7. Aesculap, Inc. (a B. Braun company)

                15.3.7.1. Company Overview

                15.3.7.2. Company Financials

                15.3.7.3. Growth Strategies

                15.3.7.4. SWOT Analysis

            15.3.8. Nurami Medical Nanofiber Technology 

                15.3.8.1. Company Overview

                15.3.8.2. Growth Strategies

                15.3.8.3. SWOT Analysis

            15.3.9. Medtronic

                15.3.9.1. Company Overview

                15.3.9.2. Company Financials

                15.3.9.3. Growth Strategies

                15.3.9.4. SWOT Analysis

            15.3.10. FOC Medical S.A. 

                15.3.10.1. Company Overview

                15.3.10.2. Growth Strategies

                15.3.10.3. SWOT Analysis

            15.3.11. Medprin Regenerative Medical Technologies Co., Ltd.

                15.3.11.1. Company Overview

                15.3.11.2. Growth Strategies

                15.3.11.3. SWOT Analysis

            15.3.12. CorMatrix, Inc.

                15.3.12.1. Company Overview

                15.3.12.2. Growth Strategies

                15.3.12.3. SWOT Analysis

            15.3.13. Terumo Corporation 

                15.3.13.1. Company Overview

                15.3.13.2. Company Financials

                15.3.13.3. Growth Strategies

                15.3.13.4. SWOT Analysis

            15.3.14. Lamed GmbH 

                15.3.14.1. Company Overview

                15.3.14.2. Growth Strategies

                15.3.14.3. SWOT Analysis

            15.3.15. South America Implants S.A.

                15.3.15.1. Company Overview

                15.3.15.2. Growth Strategies

                15.3.15.3. SWOT Analysis

    List of Tables

    Table 01: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 02: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Biologic Patch, 2017–2027

    Table 03: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Application, 2017–2027

    Table 04: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Cardiovascular Repair, 2017–2027

    Table 05: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Soft Tissue Repair, 2017–2027

    Table 06: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 07: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Region, 2017–2027

    Table 08: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 09: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Biologic Patch, 2017–2027

    Table 10: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Application, 2017–2027

    Table 11: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Cardiovascular Repair, 2017–2027

    Table 12: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Soft Tissue Repair, 2017–2027

    Table 13: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 14: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Country, 2017–2027

    Table 15: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 16: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Biologic Patch, 2017–2027

    Table 17: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Application, 2017–2027

    Table 18: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Cardiovascular Repair, 2017–2027

    Table 19: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Soft Tissue Repair, 2017–2027

    Table 20: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 21: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 22: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 23: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Biologic Patch, 2017–2027

    Table 24: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Application, 2017–2027

    Table 25: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Cardiovascular Repair, 2017–2027

    Table 26: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Soft Tissue Repair, 2017–2027

    Table 27: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 28: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 29: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 30: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Biologic Patch, 2017–2027

    Table 31: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Application, 2017–2027

    Table 32: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Cardiovascular Repair, 2017–2027

    Table 33: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Soft Tissue Repair, 2017–2027

    Table 34: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 35: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 36: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 37: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Biologic Patch, 2017–2027

    Table 38: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Application, 2017–2027

    Table 39: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Cardiovascular Repair, 2017–2027

    Table 40: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Soft Tissue Repair, 2017–2027

    Table 41: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 42: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    List of Figures

    Figure 01: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027

    Figure 02: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn), by Product, 2018

    Figure 03: Global Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Application, 2018

    Figure 04: Market Overview

    Figure 05: Global Cardiovascular & Soft Tissue Repair Patch Market Value Share, by Product, 2018

    Figure 06: Global Cardiovascular & Soft Tissue Repair Patch Market Value Share, by Application, 2018

    Figure 07: Global Cardiovascular & Soft Tissue Repair Patch Market Value Share, by End-user, 2018

    Figure 08: Global Cardiovascular & Soft Tissue Repair Patch Market Value Share, by Region, 2018

    Figure 09: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

    Figure 10: Global Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Product, 2018 and 2027

    Figure 11: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) and Y-o-Y Growth, by Synthetic Patch, 2017–2027

    Figure 12: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) and Y-o-Y Growth, by Biologic Patch, 2017–2027

    Figure 13: Global Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Product, 2019–2027

    Figure 14: Global Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Application, 2018 and 2027

    Figure 15: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) and Y-o-Y Growth, by Cardiovascular Repair, 2017–2027

    Figure 16: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) and Y-o-Y Growth, by Soft Tissue Repair, 2017–2027

    Figure 17: Global Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Application, 2019–2027

    Figure 18: Global Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 19: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) and Y-o-Y Growth, by Hospitals, 2017–2027

    Figure 20: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) and Y-o-Y Growth, by Ambulatory Surgical Centers, 2017–2027

    Figure 21: Global Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) and Y-o-Y Growth, by Specialty Clinics, 2017–2027

    Figure 22: Global Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by End-user, 2019–2027

    Figure 23: Global Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Region, 2018 and 2027

    Figure 24: Global Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Region, 2019–2027

    Figure 25: North America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 26: North America Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Product, 2018 and 2027

    Figure 27: North America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Product, 2019–2027

    Figure 28: North America Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Application, 2018 and 2027

    Figure 29: North America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Application, 2019–2027

    Figure 30: North America Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 31: North America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by End-user, 2019 -2027

    Figure 32: North America Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Country, 2018 and 2027

    Figure 33: North America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Country, 2019–2027

    Figure 34: Europe Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 35: Europe Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Product, 2018 and 2027

    Figure 36: Europe Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Product, 2019–2027

    Figure 37: Europe Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Application, 2018 and 2027

    Figure 38: Europe Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Application, 2019–2027

    Figure 39: Europe Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 40: Europe Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by End-user, 2019 -2027

    Figure 41: Europe Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 42: Europe Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 43: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 44: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Product, 2018 and 2027

    Figure 45: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Product, 2019–2027

    Figure 46: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Application, 2018 and 2027

    Figure 47: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Application, 2019–2027

    Figure 48: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 49: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by End-user, 2019 -2027

    Figure 50: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 51: Asia Pacific Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 52: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 53: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Product, 2018 and 2027

    Figure 54: Latin America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Product, 2019–2027

    Figure 55: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Application, 2018 and 2027

    Figure 56: Latin America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Application, 2019–2027

    Figure 57: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 58: Latin America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by End-user, 2019 -2027

    Figure 59: Latin America Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 60: Latin America Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 61: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 62: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Product, 2018 and 2027

    Figure 63: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Product, 2019–2027

    Figure 64: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Application, 2018 and 2027

    Figure 65: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Application, 2019–2027

    Figure 66: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 67: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by End-user, 2019 -2027

    Figure 68: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 69: Middle East & Africa Cardiovascular & Soft Tissue Repair Patch Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 70: Market Position Analysis, 2018, by Tier and Size of the Company

Copyright © Transparency Market Research, Inc. All Rights reserved